IOL Chemicals and Pharmaceuticals per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹5.73₹4.69₹3.44₹22.90₹23.70
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹5.73₹4.69₹3.44₹22.90₹23.70
₹61.27₹61.27₹57.49₹274.49₹256.81
₹85.97₹79.00₹70.83₹363.28₹377.64
—₹7.30₹6.08₹49.41₹20.83
₹1.41₹1.41−₹1.19₹2.71−₹15.25
—₹1.00₹0.80₹5.00₹4.00
29.429.429.45.95.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

IOLCP₹180.62

IOL Chemicals and Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersMOREPENLABFDCINNOVACAPORCHPHARMASENORESSANOFIGUJTHEMRPGLIFEMcap ₹5,302 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS23.7022.903.444.695.73
Diluted EPS23.7022.903.444.695.73
Book Value per Share256.81274.4957.4961.2761.27
Revenue per Share377.64363.2870.8379.0085.97
Cash Flow per Share20.8349.416.087.30—
Free Cash Flow per Share-15.252.71-1.191.411.41
Dividends per Share4.005.000.801.00—
Shares Outstanding (cr)5.95.929.429.429.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.